Latest News
Kone has agreed to acquire rival TK Elevator, which is owned by Advent International and Cinven, in a €29.4bn ($34.4bn) transaction including debt, marking one of the largest private equity exits in Europe to date, according to a report by Bloomberg.
EQT has raised €3.1bn ($3.6bn) for its latest European real estate vehicle, surpassing its €2.5bn target despite a still-challenging fundraising environment for property-focused funds, according to a report by Bloomberg.
A first-quarter snapshot of Ares Capital Corp suggests the firm is not bracing for significant fallout from the liquidity strains affecting private credit markets or from rising concerns about artificial intelligence disrupting software borrowers, according to a report by Reuters.
Private investment firm CVC Capital Partners is evaluating a potential €9bn ($10.5bn) bid for Italian payments group Nexi, as it revisits a target it has previously explored acquiring, according to a report by Reuters.
Virtusa, the global IT services provider owned by European private investment major EQT, is assessing plans for an initial public offering in India that could raise at least $1bn and value the business at $7bn or more, according to a report by Reuters.
New York City Mayor Zohran Mamdani is seeking to reduce a widely used tax benefit for hedge funds, private equity firms and other high-income business partnerships as part of efforts to close a widening municipal budget gap.
A consortium comprising Stonepeak Partners and Bernhard Capital Partners is nearing an agreement to acquire Louisiana-based utility Cleco Power in a transaction valued at approximately $5.75bn to $6 billion, according to a report by Bloomberg citing unnamed people familiar with the matter.
Shares in Swedish research technology group Cint surged on Monday after a consortium backed by UK-based private equity firm Triton Partners unveiled plans to take the company private, according to a report by Reuters.
Digital Edge, the Asia-Pacific data centre operator backed by Stonepeak Partners, is exploring strategic options including a potential partial or full sale that could value the business at up to $10bn, according to a report by Bloomberg citing unnamed people familiar with the matter.
TOP STORY: Thermo Fisher Scientific has agreed to divest its microbiology division to private equity firm Astorg in a deal valued at approximately $1.08bn, according to a company statement. The transaction will be funded through a combination of cash proceeds and a $50m seller note.
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
